Eton Pharmaceuticals Inc (ETON) — Cash Flow Reinvestment Rate
Eton Pharmaceuticals Inc (ETON) has a Cash Flow Reinvestment Rate of 0.05x as of September 2025, reinvesting $568.00K (capex $284.00K plus investments $-284.00K) from operating cash flow of $12.03 Million. Explore ETON capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eton Pharmaceuticals Inc Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Eton Pharmaceuticals Inc across 4 annual periods. Also explore total assets of Eton Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year capital reinvestment analysis for Eton Pharmaceuticals Inc. For live market cap and broader valuation context, see ETON market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $333.00K | $10.52 Million | $333.00K | ▼ -99.9% |
| 2024 | 41.32x | $40.04 Million | $969.00K | $26.00K | ▲ +18067.9% |
| 2023 | 0.23x | $1.55 Million | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 1.16x | $5.58 Million | $4.82 Million | $2.79 Million | — |